Haloperidol and Risperidone in Mania

Bipolar Psychopharmacotherapy: Caring for the Patient

Volumn , Issue , 2006, Pages 105-123

  Cookson, John ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Acute tranquillization in mania; Depot antipsychotic medication; Dopamine receptor blocking actions; Extrapyramidal side effects; Mood stabilizers; Placebo controlled design

Indexed keywords

EID: 58049120345     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470017953.ch7     Document Type: Chapter

References (46)

1. Aubrey, A. M., Simon, A. E. and Bertsky, C. (2000) Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases. Journal of Clinical Psychiatry, 61, 649-655.
2. Batchelor, D. H. and Lowe, M. R. (1990) Reported neurotoxicity with the lithium/haloperidol combination and other neuroleptics-a literature review. Human Psychopharmacology, 5, 275-280.
3. Bowden, C. L., Brugger, A. M., Swann, A. C., et al. (1994) Efficacy of Divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. Journal of the American Medical Association, 271, 918-924.
4. Busch, F. N., Miller, F. T. and Weiden, P. J. (1989) A comparison of two adjunctive treatment strategies in acute mania. Journal of Clinical Psychiatry, 50, 453-455.
5. Chou, J. C., Zito, J. M., Vitrai, J., et al. (1996) Neuroleptics in acute mania: A pharmacoepidemiologic study. Annals of Pharmacotherapy, 30, 1396-1398.
6. Coconcea, C, Shelton, M. D., Delgado, P., Amawi, L., and Calabrese, J. R. (2003) Risperidone augmentation in rapid cycling bipolar disorder. Poster presentation: Fifth International Conference on Bipolar Disorder, Pittsburg.
7. Cookson, J. C. (2001) Use of Antipsychotic Drugs and Lithium in Mania. British Journal of Psychiatry, 178, Suppl. 41: s148-s156.
8. Cookson, J. C. and Sachs, G. S. (1999) Lithium: Clinical use in mania & prophylaxis of affective disorders. In: Schizophrenia and Mood Disorders: The New Drug Therapies in Clinical Practice, eds P. F. Buckley and J. L. Waddington, Butterworth-Heinemann, Oxford.
9. Cookson, J. C., Silverstone, T. and Wells, B. (1981) A double-blind comparative clinical trial of pimozide and chlorpromazine in mania: A test of the dopamine hypothesis. Acta Psychiatrica Scandinavica, 64, 381-397.
10. Cookson, J. C., Moult, P. J. A., Wiles, D., et al. (1983) The relationship between prolactin levels and clinical ratings in manic patients treated with oral and intravenous test doses of haloperidol. Psychological Medicine, 13, 279-285.
11. Cookson, J. C., Silverstone, T., Williams, S., et al. (1985) Plasma cortisol levels in mania: Associated clinical ratings and change during treatment with haloperidol. British Journal of Psychiatry, 146, 498-502.
12. Cookson, J. C., Taylor, D., Katona, C. (2002a) Chapter 14. Violence: Assessing Risk And Acute Tranquillisation. In Use of Drugs in Psychiatry: The Evidence From Psychopharmacology, pp. 117-131. Gaskell Press, London.
13. Cookson, J. C., Taylor, D., Katona, C. (2002b) Chapter 5. Placebo Effects, Evaluating Evidence, And Combining Psychotherapy. In Use of Drugs in Psychiatry: The Evidence From Psychopharmacology, pp. 117-131. Gaskell Press, London.
14. Garfinkel, P. E., Stancer, H. C. and Persaud, E. (1980) A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. Journal of Affective Disorders, 2, 279-288.
15. Hirschfeld, R., Keck, P. E., Karcher, K., Kramer, M., Canuso, C., Eerdekens, M. and Grossman, F. (2004) Rapid antimanic effect of risperidone monotherapy: A 3-week multicenter, double-blind, placebo-controlled trial. American Journal of Psychiatry, 161, 1057-1065.
16. Khanna, S., Vieta, E., Lyons, B., Grossman, F., Eerdekens, M. and Kramer, M. (2005) Risperidone in the treatment of acute mania: Double-blind, placebo-controlled study. British Journal of Psychiatry, 187, 229-234.
17. Kleinberg, D. C., Davis, J. M., De Coster, R. et al. (1999). Prolactin levels and adverse events in patients treated with risperidone. Journal of Clinical Psychopharmacology, 19, 57-61.
18. Lenox, R. H., Newhouse, P. A., Creelman, W. L., et al. (1992) Adjunctive treatment of manic agitation with lorazepam versus haloperidol: A double-blind study. Journal of Clinical Psychiatry, 53, 47-52.
19. Licht, R. W., Bysted, M. and Christensen, H. (2001) Fixed-dose risperidone in mania: an experimental trial. International Clinical Psychopharmacology, 16, 193-110.
20. Littlejohn, R., Leslie, F. and Cookson, J. (1994) Depot antipsychotics in the prophylaxis of bipolar affective disorder. British Journal of Psychiatry, 165, 827-829.
21. Lowe, M. R. and Batchelor, D. H. (1990) Lithium and neuroleptics in the management of manic-depressive psychosis. Human Psychopharmacology, 5, 267-274.
22. Marder, S. R. and Meibach, R. C. (1994) Risperidone in the treatment of schizophrenia. American Journal of Psychiatry, 151, 825-835.
23. McGarry, L., Bird, A. P., Thompson, D., Cookson, J., Martin, S. C., and Weinstein, M. C. (2003) Cost-effectiveness of atypical antipsychotics for treatment of acute mania in the UK. Poster 1.203 at European College of Neuropsychopharmacology (ECNP) Meeting, Prague.
24. McIntyre, R. S., Brecher, M., Paulsson, B., Huizar, K. and Mullen, J. (2005) Quetiapine or haloperidol as monotherapy for bipolar mania: A 12-week, double-blind, randomised, parallel-group, placebo-controlled trial. European Neuropsychopharmacology, 15, 573-585.
25. Muller-Oerlinghausen, B., Retzow, A., Henn, F. A., Giedke, H., Walden, J. (2000) Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: A prospective, randomized, double-blind, placebo-controlled, multicentre study. Journal of Clinical Psychopharmacology, 20, 195-203.
26. Peroutka, S. J. and Snyder, S. H. (1980) Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency. American Journal of Psychiatry, 137, 1518-1522.
27. Peuskens, J. and the Risperidone Study Group (1995) Risperidone in the treatment of patients with chronic schizophrenia: A multi-national, multi-centre, double-blind, parallelgroup study versus haloperidol. British Journal of Psychiatry, 166, 712-726.
28. Post, R. M., Jimerson, D. C., Bunney, W. F., et al. (1980) Dopamine and mania: Behavioural and biochemical effects of the dopamine receptor blocker pimozide. Psychopharmacology, 67, 297-305.
29. Prien, R. F., Caffey, E. M. and Klett, C. J. (1972) Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Archives of General Psychiatry, 26, 146-153.
30. Rifkin, A., Doddi, S., Karajgi, B., et al. (1994) Dosage of haloperidol for mania. British Journal of Psychiatry, 165, 113-116.
31. Royal College of Psychiatrists (1998) Management of Imminent Violence. Clinical practice guidelines to support mental health services. Occasion paper OP41. London: The Royal College of Psychiatrists.
32. Sachs, G. S., Grossman, F., Ghaemi, S. N., Okamoto, A. and Bowden, C. L. (2002) Combination of a Mood Stabilizer With Risperidone or Haloperidol for Treatment of Acute Mania: A Double-Blind, Placebo-Controlled Comparison of Efficacy and Safety. American Journal Psychiatry, 159, 1146-1154.
33. Segal, J., Berk, M. and Brook, S. (1998) Risperidone compared with both lithium and haloperidol in mania: a double blind randomized controlled trial. Clinical Neuropharmacology, 21, 176-180.
34. Sernyak, M. J. and Woods, S. W. (1998) Chronic neuroleptic use in manic-depressive illness. Psychopharmacology Bulletin, 29, 375-381.
35. Sernyak, M. J., Griffin, R. A., Johnson, R. M., et al. (1994) Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. American Journal of Psychiatry, 151, 133-135.
36. Sernyak, M. J., Leslie, D., Alarcon, R. D., Losonczy, M. F. and Rosenheck, R. (2002) Association of Diabetes Mellitus With Use of Atypical Neuroleptics in the Treatment of Schizophrenia. American Journal of Psychiatry, 159, 561-566.
37. Shopsin, B., Gershon, S., Thompson, H., et al. (1975) Psychoactive drugs in mania: a controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Archives of General Psychiatry, 32, 34-42.
38. Singh, A. N., Golledge, H. and Catalan, J. (1997) Treatment of HIV-related psychotic disorders with risperidone: A series of 21 cases. Journal of Psychosomatic Research, 42, 489-493.
39. Smulevich, A. B., Khanna, S., Eerdekens, M., Kramer, M. and Grossman, F. (2005) Acute and continuation risperidone monotherapy in bipolar mania: A 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol. European Neuropsychopharmacology, 15, 75-84.
40. Szabadi, E., Gaszner, P. and Bradshaw, C. M. (1981) An investigation of the alphaadrenoceptor blocking properties of neuroleptics in the human iris in vivo. British Journal of Clinical Pharmacology, 11, 416-417.
41. Tohen, M., Zarate, C. A., Centorrino, Hegarty, J. I., Froeschl, M. and Zarate, S. (1996) Risperidone in the treatment of mania. Journal of Clinical Psychiatry, 57, 249-253.
42. Tohen, M., Goldberg, J. F., Gonzalez-Pinto, A. M., Azorin, J. M., Vieta, E., Hardy-Bayle, M. C., Lawson, W. P., Emsley, R. A., Baker, R. W., Risser, R. C., Namjoshi, M. A., Evans, A.R., Breier, A. (2003) A 12-week double-blind comparison of olanzapine versus haloperidol in the treatment of acute mania. Archives of General Psychiatry, 60, 1218-1226.
43. Vieta, E., Gasto, C., Colom, F. et al. (1998) Treatment of refractory rapid cycling bipolar disorder with risperidone. Journal of Clinical Psychopharmacology, 18, 172-174.
44. Vieta, E., Gasto, C., Colom, F., Reinares, M., Martinez-Aran, A., Benabarre, A. and Akiskal, H.S. (2001) Role of risperidone in bipolar-II: An open 6-month study. Journal of Affective Disorders, 67, 213-219.
45. Vieta, E., Herraiz, M., Parramon, G. et al. (2002) Risperidone in the treatment of mania: Efficacy and safety results from a large, multicentre, open study in Spain. Journal of Affective Disorders, 72, 15-19.
46. Yatham, L. N., Grossman, F., Augustyns, I., Vieta, E. and Ravindran, A. (2003) Mood stabilisers plus risperidone or placebo Mood stabilisers plus risperidone or placebo in the treatment of acute mania in the treatment of acute mania: International, double-blind, randomised controlled trial. British Journal of Psychiatry, 182, 141-147.